Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.550
-0.120 (-3.27%)
At close: Aug 14, 2026, 4:00 PM EDT
3.580
+0.030 (0.85%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.06 billion as of August 14, 2026. Its market cap has increased by 23.36% in one year.
Market Cap
1.06B
Enterprise Value
983.18M
1-Year Change
23.36%
Ranking
Category
Stock Price
$3.55
ChartMarket Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.06B, a decrease of -19.80%. That is a compound annual growth rate of -3.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.06B | -1.97% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.10B |
| Wave Life Sciences | 1.05B |
| Avalo Therapeutics | 1.04B |
| Lexicon Pharmaceuticals | 1.03B |
| Annexon | 1.01B |
| Ardelyx | 1.00B |
| Odyssey Therapeutics | 987.60M |
| Janux Therapeutics | 983.69M |